» Articles » PMID: 35781903

Variation in Ovarian Cancer Care in Australia: An Analysis of Patterns of Care in Diagnosis and Initial Treatment in New South Wales

Overview
Publisher Wiley
Specialties Nursing
Oncology
Date 2022 Jul 5
PMID 35781903
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Ovarian cancer has the highest mortality of all gynaecological cancers. This study aimed to identify the extent to which women across New South Wales experienced variation in their care in diagnosis and initial treatment for ovarian cancer against the national optimal care pathway for ovarian cancer.

Method: Clinical audit methodology was utilised to explore variations for women with primary ovarian cancer; 171 eligible cases were identified through by the NSW Cancer Registry for the period of 1 March 2017 to 28 February 2018.

Results: Limited variation was detected with 86% of women being reviewed by a specialist gynaecological oncology multidisciplinary team; 54% of women received their first treatment within 28 days of their first specialist appointment, 66% of women having their first surgery completed by a gynaecological oncologist and 45% of women received their first treatment in a specialist gynaecological oncology hospital.

Conclusion: Deviation from effective ovarian cancer care is apparent particularly in the location and timeliness of first treatment, with implications for the quality of care received and care outcomes. Understanding factors that contribute to variation is critical to ensure optimal and appropriate ovarian cancer care and to tackle systemic barriers to the provision of effective care.

Citing Articles

Variation in ovarian cancer care in Australia: An analysis of patterns of care in diagnosis and initial treatment in New South Wales.

White K, Walton R, Kwedza R, Rushton S, Currow D, Seale H Eur J Cancer Care (Engl). 2022; 31(6):e13649.

PMID: 35781903 PMC: 9787805. DOI: 10.1111/ecc.13649.

References
1.
Wennberg J . Time to tackle unwarranted variations in practice. BMJ. 2011; 342:d1513. DOI: 10.1136/bmj.d1513. View

2.
Jordan S, Francis J, Nelson A, Zorbas H, Luxford K, Webb P . Pathways to the diagnosis of epithelial ovarian cancer in Australia. Med J Aust. 2010; 193(6):326-30. DOI: 10.5694/j.1326-5377.2010.tb04065.x. View

3.
Bristow R, Tomacruz R, Armstrong D, Trimble E, Montz F . Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002; 20(5):1248-59. DOI: 10.1200/JCO.2002.20.5.1248. View

4.
Tracey E, Hacker N, Young J, Armstrong B . Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study. Int J Gynecol Cancer. 2014; 24(7):1232-40. DOI: 10.1097/IGC.0000000000000213. View

5.
White K, Walton R, Kwedza R, Rushton S, Currow D, Seale H . Variation in ovarian cancer care in Australia: An analysis of patterns of care in diagnosis and initial treatment in New South Wales. Eur J Cancer Care (Engl). 2022; 31(6):e13649. PMC: 9787805. DOI: 10.1111/ecc.13649. View